Screener
Rigel Pharmaceuticals RIGL Asset turnover
Asset turnover at other companies
Other financials
Where this comes from
Calculated from Rigel Pharmaceuticals’s reported figures.
Based on trailing twelve months.
The source filing: Rigel Pharmaceuticals’s 10-Q, filed May 5, 2026. Open the filing →
- Filed
- May 5, 2026, 4:05 PM EDT
- Fiscal quarter
- Q4 FY2026
- Calendar quarter
- Q4 2026
- Accession
- 0001034842-26-000032
FAQ
- What is Rigel Pharmaceuticals's asset turnover?
- Rigel Pharmaceuticals (RIGL) reported asset turnover of 0.9× in Q1 2026.
- How has Rigel Pharmaceuticals's asset turnover changed year-over-year?
- Rigel Pharmaceuticals's asset turnover decreased by 34.4% year-over-year, from 1.3× to 0.9×.
- What is the long-term trend for Rigel Pharmaceuticals's asset turnover?
- Over 5 years (2020 to 2025), Rigel Pharmaceuticals's asset turnover has grown at a 0.6% compound annual growth rate (CAGR), from 0.8× to 0.9×.
- What does asset turnover mean?
- Trailing-twelve-month revenue divided by average total assets. Measures how many dollars of sales each dollar of assets generates — the efficiency leg of the DuPont decomposition of ROE.
Ask your AI about Rigel Pharmaceuticals's asset turnover.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude